
@CNBC Drug development is increasingly exploring microgravity environments in low Earth orbit, as researchers look for ways space conditions could improve testing, manufacturing, and discovery processes in pharmaceuticals.
Users are excited about pharma firms developing drugs in low Earth orbit because they see microgravity as an ideal clean room for faster crystal formation, protein folding, and major medical advances.

@CNBC Drug development is increasingly exploring microgravity environments in low Earth orbit, as researchers look for ways space conditions could improve testing, manufacturing, and discovery processes in pharmaceuticals.

@CNBC Interesting time

@CNBC Drugs are very important to survive in space.

@CNBC this is a wild pivot, but it makes sense when you think about it.

@CNBC Microgravity = the ultimate clean room for crystal formation and protein folding.
Pharma in space could be the biggest catalyst for faster/cheaper drug discovery since CRISPR.
$LLAP, $RKLB, $SPCE and biotech names with space exposure about to get a lot more attention.

@CNBC Building a pipeline that bypasses expensive, high-end human spacecraft for automated, high-cadence re-entry pods is genius. A whole industrial city in low Earth orbit sounds like sci-fi, but the commercial roadmap is right there in front of us.

@CNBC Absolutly

@CNBC Hmm

@CNBC Zero gravity meds? Wild stuff tbh.

@CNBC Cool

@CNBC microgravity protein crystallization has been promising for years. wonder if the economics actually pan out this time

@CNBC 🥲

@draken1721 @CNBC Hmm

@harry_brig @CNBC Interesting

@CNBC Good use case

@LongedBitcoin @CNBC Fax

@CNBC https://open.spotify.com/track/2EZ2v43Bj5GA1S32XHSYpv?si=LykzZoPBTZC-PNWVv9xI_A&rowId=63306633643031666661626131663733&context=spotify%3Aplaylist%3A37i9dQZF1E4vefJExxDqk2